Sanofi-aventis and Merck & Co. announced the companies have signed a definitive agreement under which Merck will sell its 50% interest in the companies' current animal health joint venture, Merial Limited, to Sanofi-aventis for $4 billion.
Formed in 1997, Merial is an animal health company that is a joint venture between Merck and Sanofi-aventis. When the transaction is complete, Sanofi-aventis will own 100% of Merial.
In addition to the Merial agreement, Merck, Sanofi-aventis and Schering-Plough announced the signing of a call option agreement. Under the terms of the agreement, following the closing of the Merck/Schering-Plough merger, Sanofi-aventis would have an option to combine the Intervet/Schering-Plough Animal Health business with Merial to form an animal health joint venture owned equally by the new Merck and Sanofi-aventis.
The sale of Merck's interest in the Merial joint venture is subject to clearance by European antitrust authorities. Merck said it anticipates completing the transaction before its planned merger with Schering-Plough is finalized, which is expected to occur during the fourth quarter of 2009.
Showing posts with label Merial Limited. Show all posts
Showing posts with label Merial Limited. Show all posts
Friday, July 31, 2009
Tuesday, January 13, 2009
Merial is exclusive distributor for AviTech's in ovo injection systems
Merial Limited has become the the exclusive distributor and technical service provider of the in ovo injection systems of AviTech, LLC.
As a result, Merial offers poultry customers worldwide its portfolio of avian vaccines together with in ovo technology. Merial produces vaccines for the treatment of Marek’s Disease and Infectious Bursal Disease, that are especially suitable for in ovo administration. The company supports its vaccine operations through the development and service of administration devices, and these activities are now complemented by its exclusive distribution of AviTech’s IntelliJect and ManualJect in ovo injection systems, Merial said in a press release.
“Merial has long recognized the value of working with the industry to make our products available conveniently and efficiently. The in ovo route is becoming ever more important, and we are delighted to partner with AviTech,” said Merial’s Global Head of Avian, Alain Wille.
AviTech is a poultry equipment manufacturer that provides engineered solutions for the poultry industry. The company’s leading equipment line consists of the IntelliJect and ManualJect systems.Merial is one of the largest global avian vaccines companies, providing a comprehensive range of products.
Merial operates in more than 150 countries worldwide.
As a result, Merial offers poultry customers worldwide its portfolio of avian vaccines together with in ovo technology. Merial produces vaccines for the treatment of Marek’s Disease and Infectious Bursal Disease, that are especially suitable for in ovo administration. The company supports its vaccine operations through the development and service of administration devices, and these activities are now complemented by its exclusive distribution of AviTech’s IntelliJect and ManualJect in ovo injection systems, Merial said in a press release.
“Merial has long recognized the value of working with the industry to make our products available conveniently and efficiently. The in ovo route is becoming ever more important, and we are delighted to partner with AviTech,” said Merial’s Global Head of Avian, Alain Wille.
AviTech is a poultry equipment manufacturer that provides engineered solutions for the poultry industry. The company’s leading equipment line consists of the IntelliJect and ManualJect systems.Merial is one of the largest global avian vaccines companies, providing a comprehensive range of products.
Merial operates in more than 150 countries worldwide.
Subscribe to:
Posts (Atom)
